DaVita Inc. (DVA) Stock Score, Valuation & Financial Research
DaVita Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 40/100.
Quick answer for DVA
DaVita Inc. currently has a Wall Street Score of 40/100. The stored market price is $181.55. Its financial score is 25/100. Its valuation score is 58/100. The latest WSS change is -0.9 points. These figures are a research snapshot, not a buy or sell recommendation.
What DaVita Inc. does
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrat
DVA financial snapshot
- Wall Street Score:
- 40/100
- Current price:
- $181.55
- Market capitalization:
- $11.66B
- Revenue:
- $14.01B
- Net income:
- $847.5M
- Free cash flow:
- $1.31B
- Cash:
- $669.0M
- Total debt:
- $10.78B
- EPS:
- 11.63
- P/E ratio:
- 15.6x
- Financial score:
- 25/100
- Valuation score:
- 58/100
- Revenue score:
- 29/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $1.31B, showing positive cash generation.
- The balance sheet shows $669.0M of cash versus $10.78B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -0.9 points: DVA decreased 0.9 points because Valuation declined by 3.6 points.
What the numbers mean
Its current valuation score is 58/100, which Wall Street Score classifies as mixed within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-06.
How to research DVA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.